BG62490B1 - Соли на клавулановата киселина - Google Patents

Соли на клавулановата киселина Download PDF

Info

Publication number
BG62490B1
BG62490B1 BG101884A BG10188497A BG62490B1 BG 62490 B1 BG62490 B1 BG 62490B1 BG 101884 A BG101884 A BG 101884A BG 10188497 A BG10188497 A BG 10188497A BG 62490 B1 BG62490 B1 BG 62490B1
Authority
BG
Bulgaria
Prior art keywords
salt
clavulanic acid
benzhydrylamine
pharmaceutically acceptable
clavulanic
Prior art date
Application number
BG101884A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG101884A (en
Inventor
George L. Callewaert
Original Assignee
Spurcourt Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26306586&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG62490(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9503839.4A external-priority patent/GB9503839D0/en
Application filed by Spurcourt Limited filed Critical Spurcourt Limited
Publication of BG101884A publication Critical patent/BG101884A/xx
Publication of BG62490B1 publication Critical patent/BG62490B1/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D503/10Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
BG101884A 1995-02-25 1997-09-11 Соли на клавулановата киселина BG62490B1 (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9503839.4A GB9503839D0 (en) 1995-02-25 1995-02-25 Claulanic acid salt
GBGB9520915.1A GB9520915D0 (en) 1995-02-25 1995-10-12 Clavulanic acid salt
PCT/GB1996/000382 WO1996026944A1 (en) 1995-02-25 1996-02-21 Clavulanic acid salts

Publications (2)

Publication Number Publication Date
BG101884A BG101884A (en) 1998-10-30
BG62490B1 true BG62490B1 (bg) 1999-12-30

Family

ID=26306586

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101884A BG62490B1 (bg) 1995-02-25 1997-09-11 Соли на клавулановата киселина

Country Status (27)

Country Link
US (1) US5726170A (sk)
EP (1) EP0729961B1 (sk)
JP (1) JPH11501023A (sk)
CN (1) CN1175952A (sk)
AP (2) AP9701116A0 (sk)
AT (1) ATE211143T1 (sk)
AU (1) AU691727B2 (sk)
BG (1) BG62490B1 (sk)
BR (1) BR9607258A (sk)
CA (1) CA2213563A1 (sk)
CZ (1) CZ266697A3 (sk)
DE (1) DE69618045D1 (sk)
EE (1) EE9700186A (sk)
FI (1) FI973287A (sk)
HK (1) HK1006571A1 (sk)
IL (1) IL117217A0 (sk)
IS (1) IS4541A (sk)
MD (1) MD1744F2 (sk)
NO (1) NO973744L (sk)
NZ (1) NZ301765A (sk)
OA (1) OA10444A (sk)
PL (1) PL321871A1 (sk)
SE (1) SE9703056D0 (sk)
SK (1) SK111197A3 (sk)
TR (1) TR199700828T1 (sk)
WO (1) WO1996026944A1 (sk)
ZA (1) ZA961457B (sk)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT400033B (de) * 1992-03-10 1995-09-25 Biochemie Gmbh Neues verfahren zur isolierung und reinigung von clavulansäure und zur herstellung von pharmakologisch verträglichen salzen derselben
SI9400107A (en) 1994-03-02 1995-10-31 Lek Tovarna Farmacevtskih New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
SI9500134B (sl) 1995-04-20 2004-04-30 Lek, Postopek za pripravo čistih alkalijskih soli klavulanske kisline
AT403375B (de) * 1995-11-15 1998-01-26 Biochemie Gmbh Verfahren zur fällung von alkalisalzen der clavulansäure
ZA975198B (en) * 1996-06-13 1997-12-15 Smithkline Beecham Corp Improved process for preparing potassium clavulanate.
DZ2456A1 (fr) * 1997-04-04 2003-01-18 Smithkline Beecham Plc Procédé de préparation de sels de l'acide clavulanique.
US8034120B2 (en) * 2002-12-20 2011-10-11 Ossur Hf Suspension liner system with seal
CN103304583B (zh) * 2013-07-09 2016-01-20 山东新时代药业有限公司 一种从克拉维酸胺盐结晶母液中回收克拉维酸的方法
CN105384758B (zh) * 2015-12-01 2018-05-01 国药集团威奇达药业有限公司 克拉维酸胺盐的制备方法
CN113979856B (zh) * 2021-11-09 2024-04-19 国药集团威奇达药业有限公司 从克拉维酸钾釜残液中回收叔丁胺和异辛酸盐的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB157873A (en) * 1920-01-16 1921-08-17 Schneider & Cie Improvements in gas turbines
GB704438A (en) * 1951-04-06 1954-02-24 Chimiotherapie Lab Franc Penicillin preparations for injection
GB1508977A (en) * 1974-04-20 1978-04-26 Beecham Group Ltd Beta-lactam antibiotic from streptomyces clavuligerus
GB1543563A (en) * 1975-02-07 1979-04-04 Glaxo Lab Ltd Beta-lactam antibiotic in purified form
GB1578739A (en) * 1976-07-23 1980-11-05 Beecham Group Ltd Amine salts of clavulanic acid methods for their preparation and compositions containing them
BE862211A (fr) * 1977-12-22 1978-06-22 Beecham Group Ltd Agents antibacteriens
EP0026044B1 (en) * 1979-08-24 1983-06-08 Beecham Group Plc Amine salt of clavulanic acid, its preparation and use
AU600655B2 (en) * 1984-10-27 1990-08-23 Beecham Group Plc Preparation of clavulanic acid and its salts and esters
ES2010143A6 (es) * 1989-03-01 1989-10-16 Pharma Mar S A Pharmar Un nuevo procedimiento de obtencion del acido z(2r,5r)-3-(2-hiadroxietiliden)-7- oxo-4-oxa-1-azabiciclo(3,2,0) -heptano-2-carboxilico y de sales estares farmaceutiacamente aceptables del mismo,a partir de caldos de fermentacion de streptomyces, sp.
AT400033B (de) * 1992-03-10 1995-09-25 Biochemie Gmbh Neues verfahren zur isolierung und reinigung von clavulansäure und zur herstellung von pharmakologisch verträglichen salzen derselben
SI9300296B (sl) * 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Postopek in intermedianti za pripravo klavulanske kisline
PL306371A1 (en) * 1993-03-26 1995-03-20 Gist Brocades Nv Diamine salts of clavulanic acid

Also Published As

Publication number Publication date
IS4541A (is) 1997-08-08
CZ266697A3 (en) 1997-11-12
EP0729961A1 (en) 1996-09-04
NO973744D0 (no) 1997-08-14
CN1175952A (zh) 1998-03-11
NO973744L (no) 1997-08-14
NZ301765A (en) 1999-10-28
AU4726196A (en) 1996-09-18
SE9703056L (sv) 1997-08-25
DE69618045D1 (de) 2002-01-31
WO1996026944A1 (en) 1996-09-06
EE9700186A (et) 1998-02-16
AP9701067A0 (en) 1997-10-31
AP9701116A0 (en) 1997-10-31
JPH11501023A (ja) 1999-01-26
ZA961457B (en) 1996-09-26
BG101884A (en) 1998-10-30
SK111197A3 (en) 1998-01-14
BR9607258A (pt) 1997-12-30
MD1744F2 (ro) 2001-09-30
US5726170A (en) 1998-03-10
SE9703056D0 (sv) 1997-08-25
HK1006571A1 (en) 1999-03-05
IL117217A0 (en) 1996-06-18
FI973287A (fi) 1997-08-22
AU691727B2 (en) 1998-05-21
EP0729961B1 (en) 2001-12-19
MX9706461A (es) 1998-06-28
FI973287A0 (fi) 1997-08-08
ATE211143T1 (de) 2002-01-15
CA2213563A1 (en) 1996-09-06
TR199700828T1 (xx) 1998-04-21
PL321871A1 (en) 1997-12-22
AP749A (en) 1999-07-05
MD970269A (en) 1999-05-31
OA10444A (en) 2002-03-26

Similar Documents

Publication Publication Date Title
FR2477154A1 (fr) Bis-esters de methanediol avec des penicillines et le 1,1-dioxyde d'acide penicillanique, leur procede de production et composition pharmaceutique les contenant
DE2228012B2 (de) -Aminophenylacetamido] -penicülansäure und Verfahren zu seiner Herstellung
EP0112550B1 (de) Kristallisierte Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung
BG62490B1 (bg) Соли на клавулановата киселина
FR2688506A1 (fr) Procede de preparation de sels de l'acide clavulanique.
NO802686L (no) Fremgangsmaate for fremstilling av en ester av et klavulansyreamin
US20020193587A1 (en) Penicillin crystal and process for producing the same
KR100416946B1 (ko) 클라뷸란산염류
CH628900A5 (fr) Procede de preparation de thio-oximes derivees de cephalosporines et de penicillines.
EP0044238B1 (fr) Dérivés de céphalosporines sulfoxydes, procédé de préparation et compositions pharmaceutiques en contenant
FR2496666A1 (fr) Nouveaux derives de cephalosporine et composition pharmaceutique les contenant
DE2325065A1 (de) Neue dithiocarbonylaminoacetylcephalosporine
US5302588A (en) Crystalline (5R,6S)-2-carbamoyloxymethyl-6-[(1R)-hydroxyethyl]-2-penem-carboxylic acid and its pharmaceutical formulation
GB2298201A (en) Clavulanic acid benzhydrylamine salts
KR19980702445A (ko) 클라불란 산 염류
JPH06104670B2 (ja) 化学化合物の新規製法
MXPA97006461A (es) Sales de acido clavulanico
KR100187333B1 (ko) 클라불란산의 디아민염
DE2727977C3 (de) 7α -Methoxycephalosporinderivate und sie enthaltende Arzneimittel
EP0311521A1 (fr) Dérivés des céphalosphorines à pharmacocinétique améliorée, procédé pour leur préparation, compositions pharmaceutiques les contenant et intermédiaire de synthèse
DE3518207A1 (de) Verfahren zur herstellung von 6-(d(-)-(alpha)-4-aethyl-2,3-dioxo-1-piperazinylcarbonylamino)-phenylacetamido)-penicillansaeure-natriumsalz
MXPA97004693A (en) Clavulan acid salts
GB2129429A (en) B-lactam antibiotics
DE2534303A1 (de) Antibiotikum, verfahren zu seiner herstellung und pharmazeutisches mittel